DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 1,616 filers reported holding DANAHER CORPORATION in Q3 2020. The put-call ratio across all filers is 1.03 and the average weighting 0.7%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $22,724,297 | -3.8% | 98,229 | +3.2% | 0.93% | -12.8% |
| Q3 2023 | $23,624,826 | +0.2% | 95,223 | -3.0% | 1.07% | +3.9% |
| Q2 2023 | $23,571,120 | -6.8% | 98,213 | -2.2% | 1.03% | -8.9% |
| Q1 2023 | $25,301,035 | -9.0% | 100,385 | -4.1% | 1.13% | -9.0% |
| Q4 2022 | $27,797,702 | +0.8% | 104,731 | -1.9% | 1.24% | -10.6% |
| Q3 2022 | $27,580,000 | +1.9% | 106,777 | -0.0% | 1.38% | +6.3% |
| Q2 2022 | $27,071,000 | -11.0% | 106,782 | +3.0% | 1.30% | +3.1% |
| Q1 2022 | $30,409,000 | -12.0% | 103,666 | -1.3% | 1.26% | -6.2% |
| Q4 2021 | $34,545,000 | +3.3% | 104,995 | -4.4% | 1.35% | -4.3% |
| Q3 2021 | $33,442,000 | +5.4% | 109,846 | -7.1% | 1.41% | +5.9% |
| Q2 2021 | $31,721,000 | +15.5% | 118,204 | -3.1% | 1.33% | +10.5% |
| Q1 2021 | $27,462,000 | -4.2% | 122,010 | -5.5% | 1.20% | -10.3% |
| Q4 2020 | $28,672,000 | -1.0% | 129,069 | -4.1% | 1.34% | -11.7% |
| Q3 2020 | $28,974,000 | +15.5% | 134,558 | -5.1% | 1.52% | +8.3% |
| Q2 2020 | $25,082,000 | +23.7% | 141,839 | -3.2% | 1.40% | +9.3% |
| Q1 2020 | $20,271,000 | -13.7% | 146,456 | -4.3% | 1.28% | +7.7% |
| Q4 2019 | $23,484,000 | +8.2% | 153,011 | +1.8% | 1.19% | +1.1% |
| Q3 2019 | $21,703,000 | +5.4% | 150,268 | +4.3% | 1.18% | +5.5% |
| Q2 2019 | $20,595,000 | +4.4% | 144,107 | -3.6% | 1.12% | +0.8% |
| Q1 2019 | $19,735,000 | +29.4% | 149,481 | +1.0% | 1.11% | +17.5% |
| Q4 2018 | $15,255,000 | +0.2% | 147,943 | +5.6% | 0.94% | +13.0% |
| Q3 2018 | $15,228,000 | +16.8% | 140,141 | +6.0% | 0.84% | +11.8% |
| Q2 2018 | $13,042,000 | +8.6% | 132,164 | +7.8% | 0.75% | +7.3% |
| Q1 2018 | $12,007,000 | +8.0% | 122,629 | +2.4% | 0.70% | +12.2% |
| Q4 2017 | $11,118,000 | +15.3% | 119,787 | +6.6% | 0.62% | +12.3% |
| Q3 2017 | $9,639,000 | +20.9% | 112,367 | +18.9% | 0.55% | +16.9% |
| Q2 2017 | $7,972,000 | +5.1% | 94,466 | +6.5% | 0.47% | +3.7% |
| Q1 2017 | $7,586,000 | +20.3% | 88,693 | +9.5% | 0.46% | +18.8% |
| Q4 2016 | $6,306,000 | +11.0% | 81,014 | +11.8% | 0.38% | +6.4% |
| Q3 2016 | $5,680,000 | -11.7% | 72,469 | +13.7% | 0.36% | -12.2% |
| Q2 2016 | $6,435,000 | +1.9% | 63,717 | -4.3% | 0.41% | -1.7% |
| Q1 2016 | $6,313,000 | -9.6% | 66,549 | -11.5% | 0.42% | -11.6% |
| Q4 2015 | $6,987,000 | +10.0% | 75,228 | +1.0% | 0.47% | +3.7% |
| Q3 2015 | $6,349,000 | -0.1% | 74,499 | +0.4% | 0.46% | +4.8% |
| Q2 2015 | $6,354,000 | +2.7% | 74,237 | +1.8% | 0.44% | +3.8% |
| Q1 2015 | $6,189,000 | -99.9% | 72,894 | +8.9% | 0.42% | +10.6% |
| Q4 2014 | $5,735,799,000 | +11.1% | 66,921 | -1.5% | 0.38% | +1.1% |
| Q3 2014 | $5,160,866,000 | -3.1% | 67,924 | +0.4% | 0.38% | +2.7% |
| Q2 2014 | $5,323,880,000 | +5.5% | 67,622 | +0.5% | 0.36% | +1.7% |
| Q1 2014 | $5,046,750,000 | +1.7% | 67,290 | +4.7% | 0.36% | +1.7% |
| Q4 2013 | $4,963,883,000 | +12.6% | 64,299 | +1.1% | 0.35% | +4.7% |
| Q3 2013 | $4,409,168,000 | +9.1% | 63,606 | -0.4% | 0.34% | +3.1% |
| Q2 2013 | $4,040,503,000 | – | 63,831 | – | 0.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RobecoSam USA, Inc. | 74,961 | $7,572,000 | 9.43% |
| Corvid Peak Capital Management, LLC | 250,000 | $25,250,000 | 8.54% |
| CORTLAND ASSOCIATES INC/MO | 310,508 | $31,361,000 | 6.88% |
| Southpoint Capital Advisors LP | 1,250,000 | $126,250,000 | 6.75% |
| GREEN VALLEY INVESTORS LLC | 2,168,594 | $219,027,000 | 6.70% |
| DAVIS-REA LTD. | 75,080 | $7,595,000 | 5.39% |
| CADINHA & CO LLC | 247,143 | $24,961,000 | 5.35% |
| Espalier Global Management LLC | 47,100 | $4,757,000 | 5.25% |
| Spears Abacus Advisors LLC | 398,334 | $40,232,000 | 5.10% |
| GCA INVESTMENT MANAGEMENT, LLC | 158,064 | $15,964,000 | 5.01% |